ALDR
Neuberger Berman Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-179,500
| Closed | -$3.39M | – | 1631 |
|
|
2019
Q3 | $3.39M | Sell |
179,500
-74,050
| -29% | -$1.4M | ﹤0.01% | 912 |
|
|
2019
Q2 | $2.98M | Buy |
253,550
+119,300
| +89% | +$1.4M | ﹤0.01% | 945 |
|
|
2019
Q1 | $1.83M | Buy |
134,250
+123,750
| +1,179% | +$1.69M | ﹤0.01% | 989 |
|
|
2018
Q4 | $108K | Sell |
10,500
-19,500
| -65% | -$201K | ﹤0.01% | 1532 |
|
|
2018
Q3 | $500K | Buy |
30,000
+20,000
| +200% | +$333K | ﹤0.01% | 1314 |
|
|
2018
Q2 | $158K | Buy |
+10,000
| New | +$158K | ﹤0.01% | 1664 |
|
|
2016
Q4 | – | Sell |
-14,500
| Closed | -$475K | – | 1668 |
|
|
2016
Q3 | $475K | Sell |
14,500
-5,500
| -28% | -$180K | ﹤0.01% | 1274 |
|
|
2016
Q2 | $499K | Buy |
+20,000
| New | +$499K | ﹤0.01% | 1245 |
|
|
2016
Q1 | – | Sell |
-18,000
| Closed | -$595K | – | 1543 |
|
|
2015
Q4 | $595K | Buy |
+18,000
| New | +$595K | ﹤0.01% | 1229 |
|
|
2015
Q3 | – | Sell |
-20,000
| Closed | -$1.06M | – | 1614 |
|
|
2015
Q2 | $1.06M | Buy |
+20,000
| New | +$1.06M | ﹤0.01% | 1197 |
|
|
2015
Q1 | – | Sell |
-22,450
| Closed | -$653K | – | 1682 |
|
|
2014
Q4 | $653K | Buy |
+22,450
| New | +$653K | ﹤0.01% | 1302 |
|